Business intelligence reports for the lab diagnostics industry
Subscribe for Exclusive Access.
Subscriptions & Reports
Interested in multiple copies or more than one of our G2 reports?
Call Sokha at 855-528-6903 or email spearson@g2intelligence.com to discuss pricing.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
Brief Your CEO: Notify Your Lab Execs of Upcoming Stark Law Changes
From - Lab Compliance Advisor
One of the best ways to score points with your lab's executives is to warn them about legal changes before they happen and…
New Federal Taskforce to Speed Implementation of Emergency Use Diagnostics
From - Diagnostic Testing & Emerging Technologies
Three federal agencies announced the creation of a new taskforce to provide timely recommendations to laboratories for rapid implementation of…
Three key items to negotiate for successful payer contracts
By Steve Selbst bio
The purpose of this article is to help you, as a provider, to focus on three key items to look for in payer contracts that will help you to get profitable contracts in place…
Compliance Perspectives: How to Spot & Avoid Kickback Risks under New EKRA Law
From - Lab Compliance Advisor
A new law passed to deal with the opioid epidemic has significant ramifications for labs including but not limited to those involved in drug addiction and…
Enforcement Trends: CMS Looks to Recover $66.3 Million in Improper Specimen Validity Test Payments
From - National Intelligence Report
The opioid crackdown has made urine drug testing an even greater priority for federal health fraud enforcers. One principle target is specimen validity testing…
The Dx Pipeline: A Roundup of the Month’s Key New Product Launches
From - Laboratory Industry Report
March was the most intense month of the year so far for new diagnostic products highlighted by 23andMe's launch of a new…
ASCO Endorses CAP’s Practice Guidelines for HPV Testing in Head, Neck Cancers
From - Diagnostic Testing & Emerging Technologies
The American Society of Clinical Oncology endorsed the American Pathologists' practice guidelines for human papillomavirus (HPV) testing in…